[Skip to content]

tab rollover pre-load tab rollover pre-load tab rollover pre-load tab rollover pre-load tab rollover pre-load tab rollover pre-load
Monday 27 September 2021
Salford GP Header Montage
Latest News:
RSS icon
Medicine, tablets, pills


This is an electronic version of our Formulary written in conjunction with the Medicine Management Committee and the Pharmacy department.   The purpose of the Formulary is:

  • To promote safe, rational and cost effective prescribing within the Trust.
  • To help select the most appropriate drug amongst the many available.


This formulary is intended to act as a rapid reference source.  It is intended for the guidance of medical practitioners, nurses and other healthcare workers.


For local GPs and Non-medical prescribers working in the community there is the Greater Manchester Joint Formulary produced by the Greater Manchester Medicines Management Group (GMMMG).  The formulary ensures that patients receive seamless care across the primary-secondary care interface and reduces the need for switching programmes. All medicines recommended for use in the NHS in a NICE Technology Assessment (TA) are approved for use in Greater Manchester, the GMMMG site provides a list of medicines with a positive recommendation from  NICE and provides links to these TAs in the GMMMG formulary.  In the SRFT formulary below all the drugs with a positive NICE TA that are applicable to SRFT are included in the formulary.


How to use

All medicines are listed alphabetically using the generic name where possible.  Some brand names are used.


  1. Type the drug name in the 'Keywords' box

  2. Click on the 'Search' button

  3. Within the results, click on the 'generic name' of the medicine you are looking for.

  4. Click on the 'Link' - this will take you to further information that talks about that medicine. 



Drug NameBNF CategoryComment / Usage RestrictionsDetails
Adalimumab1.5 Chronic bowel disordersFor Crohns disease in line with NICE. Follow restricted high cost procedure -contact pharmacy if unsure of process 
Adalimumab ( Humira®), Etanercept ( Enbrel®), Certolizumab pegol ( Cimzia®) & Infliximab Biosimilar See online BNFApproved in April 2016 As per NICE TA 383: Adalimumab, certolizumab pegol, etancercept, golimumab and infliximab are recommended, within their marketing authorisations, as options for treating severe active ankylosing spondylitis in adults whose disease has responded inadequately to, or who cannot tolerate, non- steroidal anti-inflammatory drugs.  
Adapalene13.6.1 Topical preparations for acne  
Adcal D39.5.1.1 Calcium supplementsTreatment of choice for patients with PEG / enteral feeding and at the GPs discretion subject to appropriate paperwork. Approved for adults and paediatrics    
Adefovir dipivoxil5.3.3 Viral HepatitisIn line with NICE guidance for Hepatitis B (Chronic). Available if required in line with NICE - discuss with pharmacy If required. 
Adenosine2.3.2 Drugs for arrhythmias  
Adrenaline 1%11.6 Treatment of glaucomaSympathomimetics 
Adrenaline/epinephrine2.7.3 Cardiopulmonary resuscitation  
Aerochamber3.1.5 Inhaler devicesFor further information please follow the reference guide for prescribing and reviewing inhaled drug therapy by clicking on the link to the right. 
Akynzeo®See online BNFAkynzeo® is a single dose combined anti-emetic, licensed for use in preventing acute and delayed chemotherapy induced nausea and vomiting. It is formulated as a single capsule containing 0.5mg palonosetron and 300mg neputitant. Approved by MMG January 2017 for patients who have suffered from chemotherapy induced nausea and vomiting despite being prescribed standard antiemetic’s (Ondansetron, cyclizine, metoclopramide).   


All material in this section is aimed at health professionals, but is information currently held within the public domain.   Members of the public seeking advice on medicine-related matters are encouraged to speak with their GP, pharmacist or nurse, or contact NHS Direct on 0845 46 47.